These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36149579)

  • 1. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.
    Shurrab M; Jackevicius CA; Austin PC; Tu K; Qiu F; Caswell J; Michael F; Andrade JG; Ko DT
    J Interv Card Electrophysiol; 2023 Apr; 66(3):629-635. PubMed ID: 36149579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation.
    Shurrab M; Jackevicius CA; Austin PC; Tu K; Qiu F; Singh SM; Crystal E; Caswell J; Michael F; Andrade JG; Ko DT
    Am J Cardiol; 2023 Jan; 186():58-65. PubMed ID: 36343447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation.
    Xu Y; Chang AR; Inker LA; McAdams-DeMarco M; Grams ME; Shin JI
    J Am Heart Assoc; 2022 Jul; 11(14):e025723. PubMed ID: 35861836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.
    Pham P; Schmidt S; Lesko L; Lip GYH; Brown JD
    JAMA Netw Open; 2020 Apr; 3(4):e203593. PubMed ID: 32329770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.
    Becattini C; Giustozzi M; Ranalli MG; Bogliari G; Cianella F; Verso M; Agnelli G; Vedovati MC
    J Thromb Haemost; 2018 May; 16(5):833-841. PubMed ID: 29460334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation.
    Raccah BH; Erlichman Y; Pollak A; Matok I; Muszkat M
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):601-610. PubMed ID: 34060932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study.
    Zhang Y; Souverein PC; Gardarsdottir H; van den Ham HA; Maitland-van der Zee AH; de Boer A
    Br J Clin Pharmacol; 2020 Jun; 86(6):1150-1164. PubMed ID: 32022295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants.
    Shurrab M; Koh M; Jackevicius CA; Qiu F; Conlon M; Caswell J; Tu K; Austin PC; Ko DT
    Int J Cardiol Heart Vasc; 2021 Jun; 34():100788. PubMed ID: 33997261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants.
    Adam L; Feller M; Syrogiannouli L; Del-Giovane C; Donzé J; Baumgartner C; Segna D; Floriani C; Roten L; Fischer U; Aeschbacher S; Moschovitis G; Schläpfer J; Shah D; Amman P; Kobza R; Schwenkglenks M; Kühne M; Bonati LH; Beer J; Osswald S; Conen D; Aujesky D; Rodondi N;
    J Thromb Haemost; 2021 Apr; 19(4):931-940. PubMed ID: 33501722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
    Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
    Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants.
    Lee JY; Oh IY; Lee JH; Kim SY; Kwon SS; Yang HJ; Kim YK; Bang SM
    Thromb Res; 2020 Nov; 195():243-249. PubMed ID: 32823239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin-naïve or warfarin-experienced patients.
    Perino AC; Fan J; Pundi K; Schmitt S; Kothari M; Din N; Heidenreich PA; Turakhia MP
    Clin Cardiol; 2022 Sep; 45(9):960-969. PubMed ID: 35946047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
    Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
    JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
    Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Nadkarni A; Shank TC
    BMC Cardiovasc Disord; 2019 Jun; 19(1):142. PubMed ID: 31195999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
    Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
    Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.